[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558117":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":19,"responsibleParty":41,"collaborators":43,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":7,"studyType":62,"phases":7,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"University of Colorado, Denver","OTHER",null,[9,15],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Christine Hovater","CONTACT","720-777-6128","3286","christine.hovater@childrenscolorado.org",{"name":16,"role":11,"phone":12,"phoneExt":17,"email":18},"Christine Chan, MD","0990","christinel.chan@childrenscolorado.org",[20],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Children's Hospital Colorado, University of Colorado Denver","RECRUITING","Aurora","Colorado","80045","United States","US",{"type":29,"coordinates":30},"Point",[31,32],-104.83192,39.72943,{"lat":32,"lon":31},[35,38],{"name":36,"role":11,"phone":37,"phoneExt":7,"email":14},"Christine Hovater, BS","720-777-3286",{"name":39,"role":40,"phone":7,"phoneExt":7,"email":7},"Christine L Chan, MD","PRINCIPAL_INVESTIGATOR",{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[44,46],{"name":45,"class":6},"Cystic Fibrosis Foundation",{"name":47,"class":6},"Baylor College of Medicine","100558117","glucose-monitoring-in-youth-with-cystic-fibrosis-during-pulmonary-exacerbations-100558117",false,"NCT06546943","Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations","Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations (GeM-PEx)","GeM-PEx","Inclusion Criteria:\n\n* 6- 25 years old\n* Confirmed diagnosis of cystic fibrosis (based on sweat chloride and\u002For two known disease causing CF mutations)\n* access to a smart phone and\u002For internet connection and the ability to complete remote telehealth visits\n\nExclusion Criteria:\n\n* known type 1 or type 2 diabetes, monogenic diabetes\n* critical illness requiring admission to the ICU\n* pregnancy","ALL","6 Years","25 Years",{"count":60,"type":61},50,"ESTIMATED","OBSERVATIONAL","The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).",[65],"Cystic Fibrosis Pulmonary Exacerbation",[67,68,69],"cystic fibrosis related diabetes","continuous glucose monitoring","cystic fibrosis pulmonary exacerbation","2024-08-06",{"date":72,"type":73},"2024-08-09","ACTUAL",{"date":75,"type":73},"2022-02-04",{"date":77,"type":61},"2025-10-31",{"name":5,"class":6},1]